Skip to search formSkip to main contentSkip to account menu

Gemcitabine-Cisplatin Regimen

Known as: gemcitabine/cisplatin regimen 
A chemotherapy combination used to treat malignant mesothelioma, advanced non-small cell lung cancer, advanced bladder cancer, advanced cervical… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Cytotoxic chemotherapy has been the mainstay of medical therapy for metastatic urothelial cancer. Currently, the gemcitabine… 
2018
2018
Abstract Continuous endovenous administration of Endostar (CE) gradually replaced drip intravenous administration of Endostar (DE… 
2013
2013
There were an estimated 72.570 new cases and 15.210 deaths from bladder cancer in 2013. It represents 4.4% of all new cancer… 
2006
2006
15505 Aims: To determine the efficacy of gemcitabine in combination with cisplatin, and to assess the safety profile of the… 
2005
2005
BACKGROUND Although platinum-based chemotherapy has become a standard treatment for non-small cell lung cancer (NSCLC), its… 
2004
2004
The clinical case of a 73-year-old man with a history of transitional cell carcinoma of the bladder, an ulcerated mass on the… 
2004
2004
8155 AIM: This Prospective Phase II study was undertaken to determine whether a dose-modified gemcitabine-cisplatin regimen… 
Highly Cited
2002
Highly Cited
2002
New chemotherapeutic agents, including paclitaxel and gemcitabine, are active in advanced bladder carcinoma, and combination…